Expertise in
6
conditions

Dr. Kenneth N. Sall

Ophthalmology
Sall Eye Research Medical Center
11423 187th St Ste 200, 
Artesia, CA 
Expertise in
6
conditions
Sall Eye Research Medical Center
11423 187th St Ste 200, 
Artesia, CA 

Overview

Kenneth Sall is an Ophthalmologist practicing medicine in Artesia, California.

Dr. Sall is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Dry Eye Syndrome, Glaucoma, and Cataract Removal.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 6 clinical trials.

Specialties

Ophthalmology

Licenses

Ophthalmology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Sall Eye Research Medical Center
11423 187th St Ste 200, Artesia, CA 90701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
Enrollment Status: Completed
Publish Date: January 29, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Enrollment Status: Terminated
Publish Date: October 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

18 Total Publications

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
Journal: Ophthalmology science
Published: August 08, 2023
Similar Doctors
Expertise in
11
conditions
Dr. Michael S. Ip
Ophthalmology
Expertise in
11
conditions
Dr. Michael S. Ip
Ophthalmology
Referral may be required

Jules Stein Eye Institute Medical Group

625 S Fair Oaks Ave Ste 280, 
Pasadena, CA 
 (19.4 miles away)
626-817-4747
Languages Spoken:
English
See accepted insurances

Michael Ip is an Ophthalmologist practicing medicine in Pasadena, California. Dr. Ip is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Vitrectomy.

Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology
Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology
Referral required
Before you request
16661 Ventura Boulevard, Penthouse 900, 
Encino, CA 
 (31.2 miles away)
818-578-7408
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Boyer is an Ophthalmologist practicing medicine in Encino, California. Dr. Boyer is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Boyer is board certified in American Board Of Ophthalmology. Dr. Boyer is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

UCI Health Gavin Herbert Eye Institute - Irvine

850 Health Sciences Road, 
Irvine, CA 
 (20.4 miles away)
949-824-2020
Languages Spoken:
English, Portuguese, Spanish
See accepted insurances

Dr. Baruch D. Kuppermann is board-certified UCI Health ophthalmologist who specializes in macular degeneration, eye inflammation and retina and vitreous surgery.He earned his medical degree at the University of Miami in Florida and PhD in neuroscience at the California Institute of Technology. He completed a residency in ophthalmology at the University of Southern California’s Doheny Eye Institute, followed by fellowships in retina and vitreous surgery at St. Joseph Medical Center in Baltimore, Md., and UC San Diego.Kupperman's research focus is on the toxicity of drugs on retinal cells and has conducted many clinical trials to evaluate new drugs and technologies for age-related macular degeneration, diabetic retinopathy and retinal vein occlusion. He is also active in the development of drug delivery systems for the posterior eye segment in collaboration with the Department of Biomedical Engineering at UC Irvine.He has been recognized as among the Best Doctors in America® and has been repeatedly named a Physician of Excellence by the Orange County Medical Association for nearly a decade.Kuppermann sees patients inOrangeandIrvine. Dr. Kuppermann is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Vein Occlusion, and Vitrectomy. Dr. Kuppermann is board certified in American Board Of Ophthalmology - Ophthalmology.

Frequently Asked Questions about Dr. Kenneth N. Sall

How do I make an appointment with Dr. Kenneth N. Sall?

You can book an appointment with Dr. Kenneth N. Sall by calling their office at 562-865-8720. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kenneth N. Sall a top-rated expert for Ocular Hypertension (OHT)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenneth N. Sall is classified as an Advanced expert for Ocular Hypertension (OHT), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kenneth N. Sall specialize in?

While Dr. Kenneth N. Sall is a Ophthalmology, they have specific expertise in Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, and Dry Eye Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Kenneth N. Sall participate in research or clinical trials?

Yes. Dr. Kenneth N. Sall has published 18 articles and abstracts on conditions like Ocular Hypertension (OHT). You can view a list of Dr. Kenneth N. Sall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kenneth N. Sall accept my insurance?

Dr. Kenneth N. Sall accepts most major insurance plans, including Humana and Wellcare. We recommend calling the office directly at 562-865-8720 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sall's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile